The utility of pre-treatment inflammation markers as associative factors to the adverse outcomes of vulvar cancer: a study on staging, nodal involvement, and metastasis models

HIGHLIGHTS

• who: Hariyono Winarto and collaborators from the Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, Faculty of Medicine, DrCipto Mangunkusumo Hospital, Jakarta, cross-sectional study was conducted on , women with VC in a single centre in Jakarta, Indonesia have published the article: The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models, in the Journal: (JOURNAL) of 31/Dec/2020
• what: Background: Given the role of inflammation in carcinogenesis this study investigated the utility of pre-treatment inflammatory . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.